Cargando…
Correction: PIK3CA mutation correlates with mTOR pathway expression but not clinical and pathological features in Fibro-adipose vascular anomaly (FAVA)
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063178/ https://www.ncbi.nlm.nih.gov/pubmed/35501918 http://dx.doi.org/10.1186/s13000-022-01224-5 |
| _version_ | 1784699110157189120 |
|---|---|
| author | Hori, Yumiko Hirose, Katsutoshi Ozeki, Michio Hata, Kenji Motooka, Daisuke Tahara, Shinichiro Matsui, Takahiro Kohara, Masaharu Higashihara, Hiroki Ono, Yusuke Tanaka, Kaishu Toyosawa, Satoru Morii, Eiichi |
| author_facet | Hori, Yumiko Hirose, Katsutoshi Ozeki, Michio Hata, Kenji Motooka, Daisuke Tahara, Shinichiro Matsui, Takahiro Kohara, Masaharu Higashihara, Hiroki Ono, Yusuke Tanaka, Kaishu Toyosawa, Satoru Morii, Eiichi |
| author_sort | Hori, Yumiko |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9063178 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90631782022-05-04 Correction: PIK3CA mutation correlates with mTOR pathway expression but not clinical and pathological features in Fibro-adipose vascular anomaly (FAVA) Hori, Yumiko Hirose, Katsutoshi Ozeki, Michio Hata, Kenji Motooka, Daisuke Tahara, Shinichiro Matsui, Takahiro Kohara, Masaharu Higashihara, Hiroki Ono, Yusuke Tanaka, Kaishu Toyosawa, Satoru Morii, Eiichi Diagn Pathol Correction BioMed Central 2022-05-02 /pmc/articles/PMC9063178/ /pubmed/35501918 http://dx.doi.org/10.1186/s13000-022-01224-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Hori, Yumiko Hirose, Katsutoshi Ozeki, Michio Hata, Kenji Motooka, Daisuke Tahara, Shinichiro Matsui, Takahiro Kohara, Masaharu Higashihara, Hiroki Ono, Yusuke Tanaka, Kaishu Toyosawa, Satoru Morii, Eiichi Correction: PIK3CA mutation correlates with mTOR pathway expression but not clinical and pathological features in Fibro-adipose vascular anomaly (FAVA) |
| title | Correction: PIK3CA mutation correlates with mTOR pathway expression but not clinical and pathological features in Fibro-adipose vascular anomaly (FAVA) |
| title_full | Correction: PIK3CA mutation correlates with mTOR pathway expression but not clinical and pathological features in Fibro-adipose vascular anomaly (FAVA) |
| title_fullStr | Correction: PIK3CA mutation correlates with mTOR pathway expression but not clinical and pathological features in Fibro-adipose vascular anomaly (FAVA) |
| title_full_unstemmed | Correction: PIK3CA mutation correlates with mTOR pathway expression but not clinical and pathological features in Fibro-adipose vascular anomaly (FAVA) |
| title_short | Correction: PIK3CA mutation correlates with mTOR pathway expression but not clinical and pathological features in Fibro-adipose vascular anomaly (FAVA) |
| title_sort | correction: pik3ca mutation correlates with mtor pathway expression but not clinical and pathological features in fibro-adipose vascular anomaly (fava) |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063178/ https://www.ncbi.nlm.nih.gov/pubmed/35501918 http://dx.doi.org/10.1186/s13000-022-01224-5 |
| work_keys_str_mv | AT horiyumiko correctionpik3camutationcorrelateswithmtorpathwayexpressionbutnotclinicalandpathologicalfeaturesinfibroadiposevascularanomalyfava AT hirosekatsutoshi correctionpik3camutationcorrelateswithmtorpathwayexpressionbutnotclinicalandpathologicalfeaturesinfibroadiposevascularanomalyfava AT ozekimichio correctionpik3camutationcorrelateswithmtorpathwayexpressionbutnotclinicalandpathologicalfeaturesinfibroadiposevascularanomalyfava AT hatakenji correctionpik3camutationcorrelateswithmtorpathwayexpressionbutnotclinicalandpathologicalfeaturesinfibroadiposevascularanomalyfava AT motookadaisuke correctionpik3camutationcorrelateswithmtorpathwayexpressionbutnotclinicalandpathologicalfeaturesinfibroadiposevascularanomalyfava AT taharashinichiro correctionpik3camutationcorrelateswithmtorpathwayexpressionbutnotclinicalandpathologicalfeaturesinfibroadiposevascularanomalyfava AT matsuitakahiro correctionpik3camutationcorrelateswithmtorpathwayexpressionbutnotclinicalandpathologicalfeaturesinfibroadiposevascularanomalyfava AT koharamasaharu correctionpik3camutationcorrelateswithmtorpathwayexpressionbutnotclinicalandpathologicalfeaturesinfibroadiposevascularanomalyfava AT higashiharahiroki correctionpik3camutationcorrelateswithmtorpathwayexpressionbutnotclinicalandpathologicalfeaturesinfibroadiposevascularanomalyfava AT onoyusuke correctionpik3camutationcorrelateswithmtorpathwayexpressionbutnotclinicalandpathologicalfeaturesinfibroadiposevascularanomalyfava AT tanakakaishu correctionpik3camutationcorrelateswithmtorpathwayexpressionbutnotclinicalandpathologicalfeaturesinfibroadiposevascularanomalyfava AT toyosawasatoru correctionpik3camutationcorrelateswithmtorpathwayexpressionbutnotclinicalandpathologicalfeaturesinfibroadiposevascularanomalyfava AT moriieiichi correctionpik3camutationcorrelateswithmtorpathwayexpressionbutnotclinicalandpathologicalfeaturesinfibroadiposevascularanomalyfava |